Small-Joint Reconstructive Implants | Market Insights | US | 2024
The US reconstructive small-joint implant market has largely recovered from the negative impacts of the COVID-19 pandemic and will resume prepandemic growth trends in the near term; going forward, growth will be driven by high growth in certain subsegments, such as those for shoulder and total ankle arthroplasty. Adoption of small-joint reconstructive implants is rising due to positive clinical results and a favorable reimbursement environment in the US. The shift to outpatient and ASC settings, which has been accelerated by the COVID-19 pandemic, will continue as reimbursement becomes more favorable in these settings, while high product ASPs, supported by ongoing product innovation and comparatively low pricing pressure in this underpenetrated market, will further contribute to revenue expansion.
This Medtech 360 Report provides comprehensive data and analysis on the state of the US market for small-joint reconstructive implants from 2019 through 2032.
